Particle.news

Download on the App Store

Carmat Files for Judicial Restructuring After Financing Shortfall

Suspended from trading on June 30 pending a court ruling the firm is exploring financing options to maintain support for 122 Aeson recipients.

Créée en 2008, Carmat avait expliqué devoir rassembler au moins 3,5 millions d'euros d'ici au 30 juin
Un employé de Carmat travaille sur un cœur artificiel autorégulé, en janvier, au siège de l’entreprise à Bois-d’Arcy.
Sa première implantation sur un patient a lieu en 2014. (Photo d'archives)
Un employé de Carmat travaille sur un coeur artificel, au siège de l'entreprise à Bois-d'Arcy (Yvelines), le 16 janvier 2024

Overview

  • Carmat announced cessation of payments on June 30 and applied to the Versailles Economic Court to open judicial restructuring proceedings.
  • The company requested suspension of its stock trading from June 30 as its share price collapsed from over €100 to around €0.30.
  • Despite launching a public donation campaign on June 20, Carmat failed to secure the €3.5 million needed by June 30 or the €20 million aimed for year-end.
  • The firm employs 180 staff across Vélizy-Villacoublay and Bois-d’Arcy and continues to pursue investors and government backing to sustain its operations.
  • Carmat says it will continue device support for 122 patients implanted with its Aeson artificial heart throughout the restructuring process.